A Trial of SHR-2173 in Healthy Volunteers

NCT07390747 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Immunology

Interventions

DRUG: SHR-2173 Injection/SHR-2173 placebo

Sponsor

Atridia Pty Ltd.